Brokers Issue Forecasts for HSCS Q3 Earnings

Heart Test Laboratories, Inc. (NASDAQ:HSCS) – Stock analysts at Ascendiant Capital Markets issued their Q3 2025 earnings per share estimates for Heart Test Laboratories in a research report issued to clients and investors on Monday, January 20th. Ascendiant Capital Markets analyst L. Ward expects that the company will post earnings per share of ($2.41) for the quarter. The consensus estimate for Heart Test Laboratories’ current full-year earnings is ($9.82) per share. Ascendiant Capital Markets also issued estimates for Heart Test Laboratories’ Q4 2025 earnings at ($2.46) EPS, FY2025 earnings at ($9.82) EPS, Q1 2026 earnings at ($2.18) EPS, Q2 2026 earnings at ($2.11) EPS, Q3 2026 earnings at ($2.13) EPS, Q4 2026 earnings at ($1.93) EPS and FY2026 earnings at ($8.35) EPS.

Heart Test Laboratories (NASDAQ:HSCS) last announced its quarterly earnings data on Monday, December 16th. The company reported ($2.27) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.30) by $0.03. During the same quarter in the prior year, the firm earned ($15.92) earnings per share.

Separately, Maxim Group restated a “buy” rating and set a $12.00 target price on shares of Heart Test Laboratories in a research report on Wednesday, December 18th.

Heart Test Laboratories Stock Up 0.6 %

NASDAQ:HSCS opened at $3.49 on Wednesday. The stock’s fifty day simple moving average is $3.43 and its 200-day simple moving average is $3.51. The firm has a market capitalization of $3.42 million, a P/E ratio of -0.44 and a beta of 2.90. The company has a quick ratio of 1.52, a current ratio of 1.72 and a debt-to-equity ratio of 0.01. Heart Test Laboratories has a 12-month low of $2.36 and a 12-month high of $18.50.

Heart Test Laboratories Company Profile

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.